| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1755eede76ea7e719a3e0d2843cd793 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
1992-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dedc3fbac7bdf9e44f78750003a8844b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b8c03101a024b7be7e754c10c7917a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c722e8494979e266f8e22b18eddb24d4 |
| publicationDate |
1993-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H05186371-A |
| titleOfInvention |
Transdermal formulation |
| abstract |
(57) [Summary] [Purpose] A percutaneous absorption preparation capable of percutaneously absorbing a sufficient amount of a drug to exert a desired drug effect and reducing skin irritation by an absorption promoter as much as possible. I will provide a. [Structure] A percutaneous absorption preparation comprising a drug and an absorption enhancer in a base, wherein lactic acid and polyoxyethylene alkyl ether phosphate represented by the following formulas (1) and (2) are used as the absorption enhancer. And at least one compound selected from the group consisting of lauric acid diethanolamide salt. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005047906-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005047908-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11507361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009534343-A |
| priorityDate |
1991-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |